As labs and diagnostic developers race to meet demand for assays to detect the SARS-CoV2 coronavirus, 360Dx is updating this tracker on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the US, European, and Asian markets.
The tracker includes only those tests that are available for diagnostic use. Links to primary regulatory decisions are provided where available.
360Dx is our sister publication, which provides in-depth coverage of in vitro diagnostics and the clinical lab market.
